Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pfizer Inc. stock logo
PFE
Pfizer
$25.61
+1.5%
$23.80
$20.92
$31.54
$143.50B0.5841.80 million shs51.25 million shs
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$139.05
-1.0%
$122.82
$72.93
$143.20
$5.99B1.771.21 million shs1.11 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pfizer Inc. stock logo
PFE
Pfizer
-0.84%+3.96%+8.01%+16.03%-10.05%
Shake Shack, Inc. stock logo
SHAK
Shake Shack
-0.68%-0.38%+8.51%+85.13%+62.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Pfizer Inc. stock logo
PFE
Pfizer
4.9747 of 5 stars
3.23.04.24.53.31.73.1
Shake Shack, Inc. stock logo
SHAK
Shake Shack
3.5047 of 5 stars
2.22.00.01.62.32.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pfizer Inc. stock logo
PFE
Pfizer
2.45
Hold$28.5511.48% Upside
Shake Shack, Inc. stock logo
SHAK
Shake Shack
2.35
Hold$124.43-10.52% Downside

Current Analyst Ratings Breakdown

Latest SHAK and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$127.00
7/2/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$140.00 ➝ $150.00
6/26/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$125.00 ➝ $160.00
6/26/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$166.00
6/26/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$105.00
6/26/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$102.00 ➝ $166.00
6/25/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$100.00 ➝ $110.00
6/25/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$112.00 ➝ $134.00
6/4/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$120.00 ➝ $145.00
6/2/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
5/29/2025
Pfizer Inc. stock logo
PFE
Pfizer
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold$28.00 ➝ $25.00
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.43 per share5.78$15.62 per share1.64
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$1.25B4.74$3.39 per share40.96$11.61 per share11.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3818.568.450.9212.62%20.33%8.53%8/5/2025 (Estimated)
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$10.21M$0.28496.6186.913.320.97%8.45%2.44%7/30/2025 (Estimated)

Latest SHAK and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/AN/AN/A$13.43 billionN/A
5/1/2025Q1 2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$0.16$0.14-$0.02$0.10$330.24 million$320.90 million
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.72%N/A124.64%16 Years
Shake Shack, Inc. stock logo
SHAK
Shake Shack
N/AN/AN/AN/AN/A

Latest SHAK and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96
Shake Shack, Inc. stock logo
SHAK
Shake Shack
0.50
1.91
1.88

Institutional Ownership

CompanyInstitutional Ownership
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Shake Shack, Inc. stock logo
SHAK
Shake Shack
86.07%

Insider Ownership

CompanyInsider Ownership
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Shake Shack, Inc. stock logo
SHAK
Shake Shack
9.73%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Shake Shack, Inc. stock logo
SHAK
Shake Shack
12,82642.67 million38.52 millionOptionable

Recent News About These Companies

Does Shake Shack Really Still Use Frozen Fries?
Shake Shack to open at Ross Park Mall
Shake Shack coming soon to Ross Park Mall
Shake Shack (NYSE:SHAK) Price Target Raised to $150.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Pfizer stock logo

Pfizer NYSE:PFE

$25.61 +0.37 (+1.47%)
Closing price 03:59 PM Eastern
Extended Trading
$25.58 -0.03 (-0.12%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Shake Shack stock logo

Shake Shack NYSE:SHAK

$139.05 -1.36 (-0.97%)
Closing price 03:59 PM Eastern
Extended Trading
$140.70 +1.65 (+1.19%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally. Its Shacks offers hamburgers, chicken, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and other products. The company was founded in 2001 and is headquartered in New York, New York.